Journal
GROWTH HORMONE & IGF RESEARCH
Volume 24, Issue 6, Pages 245-250Publisher
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.ghir.2014.10.003
Keywords
Stem cells; Growth hormone; Nanotopology; Osteogenesis
Categories
Funding
- Bioscience and Biotechnology Research Council [BB/K006908/1]
- Biotechnology and Biological Sciences Research Council [BB/D015324/1, BB/K006908/1] Funding Source: researchfish
- British Heart Foundation [PG/10/26/28303] Funding Source: researchfish
- BBSRC [BB/D015324/1, BB/K006908/1] Funding Source: UKRI
Ask authors/readers for more resources
Custom engineered materials can influence the differentiation of human mesenchymal stem cells (MSCs) towards osteoblasts, chondrocytes and adipocytes, through the control of chemistry, stiffness and nanoscale topography. Here we demonstrate that polycaprolactone growth surfaces engineered with disordered (but controlled) 120 nm diameter dots (NSQ50), but not flat surfaces, promote osteogenic conversion of MSCs in the absence of other osteogenic stimuli. Differentiating MSCs on NSQ50 were found to express growth hormone receptors (GH) and stimulation with recombinant human GH (rhGH) further enhanced NSQ50-driven osteogenic conversion of MSCs. This increased osteogenesis coincided with an enhanced ability of GH to activate ERK MAP kinase on NSQ50, but not on flat topology. The importance of ERK for MSC differentiation was demonstrated by using the inhibitor of ERK activation, U0126, which completely suppressed osteogenesis of GH-stimulated MSCs on NSQ50. The ability of GH to activate ERK in MSCs may therefore be a central control mechanism underlying bone development and growth. (C) 2014 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available